Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2013-11-20
Original SEC Filing: Click here

---

Webplus: TPI/20131120/8-K/2_EX-99.1/000.htm SEC Original: f8k111513ex99i_tianyinpharma.htm
TPI Reports First Quarter Fiscal Year 2014 Financial Results November 15, 2013 Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the first quarter fiscal year 2014. First Quarter Fiscal Year 2014 Ended September 30, 2013 Financial Highlights:

---

---

Webplus: TPI/20131120/8-K/3_EX-99.2/000.htm SEC Original: f8k111513ex99ii_tianyinpharm.htm
Tianyin Pharmaceutical Inc. First Quarter Fiscal Year 2014 Financial Results Conference Call November 15, 2013 Operator. I will now turn the presentation over to James Tong. Please go ahead, Mr. Tong. James Tong Below are the financial highlights for the first quarter of fiscal year 2014 ended September 30, 2013: Revenue totaled $14.8 million, compared with $16.0 million in the

---

---

Webplus: TPI/20131120/8-K/1/000.htm SEC Original: f8k111513_tianyinpharma.htm
CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT November 15, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o

---

Company Information:

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2013-11-20CIK: 0001362718, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
23RD FLOOR, UNIONSUN YANGKUO PLAZA
CHENGDU, P.R. 610041